LUNG 6.2 (+3.33%)
US7458481014Medical Devices & InstrumentsMedical Devices

Pulmonx (LUNG) Financial Metrics

This table shows a selected set of financial data points of Pulmonx (LUNG). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -1.6 0 -7.96 484.18M -0.33 68.68M -38.42M -55.49M -60.84M 83.55M
2022 -1.59 0 -5.31 312.72M -0.27 53.66M -46.4M -55.99M -58.92M 101.74M
2021 -1.35 0 -23.81 1.16B -0.2 48.42M -45.06M -46.62M -48.66M 148.48M
2020 -3.16 0 -21.81 702.96M -0.2 32.73M -31.54M -28.35M -32.23M 231.56M
2019 -1 0 0 0 -0.6 32.6M -21.49M -17.66M -20.7M 14.77M
2018 -0.89 0 0 0 -2.24 20M -18.71M -15.68M -18.48M 4.12M
2017 0 0 0 0 -5.26 0 0 0 -5.37M 636.64K
2016 0 0 0 0 -3.5 8.8K 0 0 -2.78M 28.92K
2015 0 0 0 0 -3.79 19.45K 0 0 -2.8M 451.53K
2014 0 0 0 0 -6.65 332.01K 0 0 -1.92M 4.04K
2013 0 0 0 0 0 115K 0 0 -1.23M 87.08K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.